The Office of Cannabis Regulations in the U.S. Virgin Islands has unveiled new draft rules, inviting public input until October 10.
The draft rules also detail qualifying conditions for medical cannabis patients and permit sacramental cannabis use for authorized religious members, with ongoing revisions expected.
After Governor Albert Bryan Jr.'s January approval of cannabis legalization, the Cannabis Advisory Board faces challenges, including a lack of quorum and the need for legal amendments.
Don't miss the chance to meet Governor Bryan in person and learn more about the US Virgin Islands and exciting investment opportunities and strategic partnerships in the thriving cannabis industry at the upcoming Benzinga Cannabis Capital Conference, in Chicago, on September 27 and 28.
Draft Rules
The draft rules outline qualifying conditions for medical cannabis patients, including:
- Cancer
- Glaucoma
- HIV/AIDS
- Hepatitis C
- ALS (Amyotrophic lateral sclerosis)
- Crohn’s disease
- Parkinson’s disease
- Post-Traumatic Stress Disorder (PTSD)
- Multiple sclerosis
- Severe nausea
- Autism
- And any condition for which a practitioner would prescribe an opiate for pain, and “any other conditions” that a medical practitioner certifies in writing where the potential benefits of medicinal use of cannabis “would likely outweigh the health risks for the Qualified Patient,” as reported per local media.
Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo by Deon A. Webster on Unsplash.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.